T he neurocutaneous syndromes are a heterogeneous group of congenital or hereditary conditions primarily involving structures derived from the embryological neuroectoderm. All of them involve the central nervous system, but peripheral nerves, skin, and other organ systems, mesodermal or endodermal in origin, may also be involved. 1 Each disorder varies greatly from the others in clinical presentation, genetics, pathologic findings, and imaging characteristics. Although the etiopathogenesis of the various forms of neurocutaneous syndromes is quite different, it has been recently suggested that a common feature could be the abnormal development of the neural crest. 2 In the neurocutaneous syndromes, diverse features result from abnormal neural crest differentiation. Cutaneous hyperpigmented or hypopigmented streaks that follow the lines of Blaschko probably represent the migratory pathways of rhomboencephalic neural crest. 2, 3 Angiomas, a common feature in many neurocutaneous syndromes, are mesodermal in origin.
Tuberous sclerosis complex is the prototype of multisystemic involvement, with hamartomas not only in the brain and skin (ectoderm), but also in the heart and kidneys (mesoderm) and liver (endoderm). In tuberous sclerosis complex, some cutaneous lesions such as the facial angiofibromas are of mesodermal origin.
Sturge-Weber syndrome has been subdivided into 3 types: type 1 (classic form) with complete facial, cutaneous, and cerebral manifestations; type 2 with facial nevus but no evidences of intracranial involvement; and type 3 with exclusive leptomeningeal angioma. 4 The etiopathogenesis of the disease is poorly understood: familiar cases are rare, and there are not similarities in monozygotic twins, so a somatic mutation event has been hypothesized. 5 Magnetic resonance imaging (MRI) features of Sturge-Weber syndrome include leptomeningeal angiomatosis, cortical and pial calcifications, and angiomatous change of the choroid plexus. Evolution of MRI abnormalities is largely unknown. 6 Several neurocutaneous syndromes have been reported to be found in association with tuberous sclerosis complex. In the past, some reports have drawn attention on the coexistence of clinical and pathological findings of tuberous sclerosis complex and Sturge-Weber syndrome in the same patient. This association was first reported by Greig, who described a patient with a meningeal nevus and adenoma sebaceum. 7 Giampalmo reported a complete association of tuberous sclerosis complex and Sturge-Weber syndrome with all the characteristic clinical and histopathological manifestations of the 2 disorders. 8 In this issue of the Journal of Child Neurology, Ramantani et al 9 reported on a tuberous sclerosis complex patient with a remarkably mild clinical phenotype associated with a new heterozygous missense mutation in exon 13 of the TSC2 gene. In this patient, MRI findings revealed a cerebellar pial angiomatosis with leptomeningeal enhancement compatible with Sturge-Weber syndrome type 3. The coexistence of intracranial features of Sturge-Weber syndrome in tuberous sclerosis complex patients has only rarely been reported in the literature (Table) . We recently reported an additional observation of a patient with confirmed diagnosis of tuberous sclerosis complex, and a de novo mutation involving exon 27 of the TSC2 gene. The MRI demonstrated multiple bilateral tubers, and in addition a diffuse enhancement along right temporooccipital leptomeningeal surfaces, compatible with the diagnosis of pial angiomatosis (Figure1). This picture is surprisingly similar to the MRI image published by Kremer et al. 10 Several hypotheses can be raised to explain the possible association observed between the 2 disorders. First of all, both tuberous sclerosis complex and Sturge-Weber syndrome lesions may be caused by neural crest defects. An abnormal segmental melanocytic distribution could in part explain the cutaneous lesions of tuberous sclerosis complex, the dermal facial angiofibromas also being derived from mesencephalic neural crest. In Sturge-Weber syndrome, the cutaneous vascular lesions observed along the distribution of the trigeminal nerve are in territories corresponding to neural crest migrations that form both nerve sheaths and small blood vessels. These lesions could also be due to the secretion of neurotrophic factors by fetal sensory nerves that cause an uncontrolled angiogenesis and an abnormality of the neurovascular bundles in the embryo. Abnormal development of neural crest could be responsible for the abnormalities of membranous bones of the cranial vault, observed both in the case of Kremer et al and in our patient. 2 Second, an abnormal angiogenesis may play a role in tuberous sclerosis complex and Sturge-Weber syndrome. Increased expression of vascular endothelial growth factor (VEGF), its receptors VEGFR-1 and 2, and an increased proliferation and apoptosis of endothelial cells were recently observed in Sturge-Weber syndrome patients. 15 All of these events could be induced by hypoxia-inducible factor (HIF) in the response to hypoxia. The HIF system is thought to contribute to hamartoma development through increased expression of growth factors such as transforming growth factor alpha, platelet-derived growth factor beta, and VEGF, and to influence glucose uptake and metabolism, mitogenesis, and tissue angiogenesis. Interestingly, HIF is regulated by growth factors involving TSC1/2. Specifically, TSC2-deficient cells fail to downregulate HIF and determine increased expression of HIF target genes, like VEGF, suggesting a role in TSC2 tumor suppression function. 16 Mammalian target of rapamycin (mTOR) dysregulation in tuberous sclerosis complex, and its altered regulation of HIF and VEGF, could lead to anomalous angiogenesis in response to the hypoxia, suggesting that the coexistence of signs of both diseases in the same patient could be explained by mutually enhanced common altered pathways. A significant increase in the fibronectin protein and in its gene expression were found in the port wine-derived fibroblasts and in the brain of a patient with Sturge-Weber syndrome. 17 This finding may explain the incomplete regression of the primitive embryonal vascular plexus, resulting in angiomatous changes.
A better understanding of the primordial role of neural crest in the pathogenesis of the neurocutaneous syndromes could enable further subclassifications of these disorders based on a common pathogenesis of abnormal neural crest induction of nonneural tissues. 2 Ultimately, the classification of the neurocutaneous syndromes will rest on the identification of genetic mutations and their interrelations with embryonic neural crest. How the defective gene interacts with many other genes, and with transcription factors during normal neural crest development, offers the promise of insights into the pathogenesis of these disorders. 2 Therefore, mutation characterization and a better definition of the clinical and neuroimaging phenotypes of these identities by neuropediatricians could offer a crucial contribution to the etiopathogenetic mechanisms of these disorders.
